Akèy › Histiyositoz selil Langerhans › Kalifòni
Etid klinik pou Histiyositoz selil Langerhans nan Kalifòni
3 etid pou Histiyositoz selil Langerhans ap chèche patisipan nan sit nan Kalifòni.
Tèks ofisyèl etid la (Anglè)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
- Kaiser Permanente Downey Medical Center, Downey
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- ak 6 plis
Ap rekriteFaz 2
180 Days – 22 Years · Tout sèks · Mizajou Oct 2, 2026 · NCT05828069Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders
- Children's Hospital of Orange County, Orange
- UCSF Benioff Children's Hospital, San Francisco
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Sep 18, 2025 · NCT04079179Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
- Stanford Children's Hospital, Lucile Packard Children's Hospital, Palo Alto
- Rady Children's Hospital - San Diego, San Diego
Ap rekriteFaz 3
Jiska laj 21 · Tout sèks · Mizajou Sep 11, 2025 · NCT02670707Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.